Continuum Advisory, LLC Astrazeneca PLC Transaction History

Continuum Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$65.37 - $77.96 $26,605 - $31,729	-407 Reduced 31.55%	883 $64,000
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $5,751 - $7,241	91 Added 7.59%	1,290 $84,000
Q3 2024 Nov 15, 2024	BUY	$76.67 - $87.62 $5,366 - $6,133	70 Added 6.2%	1,199 $93,000
Q2 2024 Jul 19, 2024	SELL	$66.81 - $80.83 $13,696 - $16,570	-205 Reduced 15.37%	1,129 $88,000
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $81,414 - $92,806	1,334 New	1,334 $90,000

1,510

501M

5.59M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Continuum Advisory, LLC with notifications on news.